Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual Meeting

被引:1
作者
Ball, Gretchen D.
Yee, Danielle
Zhang, Arianna J.
Perez-Chada, Lourdes M. [1 ]
Strand, Vibeke
Merola, Joseph F. [2 ]
Armstrong, April W.
Gottlieb, Alice B.
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, 41 Ave Louis Pasteur,EC 313, Boston, MA 02115 USA
[2] UT Southwestern Med Ctr, Dept Med, Div Rheumatol, Dallas, TX USA
基金
美国国家卫生研究院;
关键词
dermatology; GRAPPA; outcome assessment; psoriasis; psoriatic arthritis; rheumatology; PSORIATIC-ARTHRITIS;
D O I
10.3899/jrheum.2024-0327
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
. The nonprofit organization International Dermatology Outcome Measures (IDEOM) is committed to improving the implementation of patient-centered outcome measures in dermatologic disease. At a conferannual meeting, the IDEOM Psoriatic Disease Workgroup presented updates on recent efforts in outcome measure advancement. Dr. Alice Gottlieb presented the preliminary findings of a study within the Mount Sinai Health System that aims to determine how well the IDEOM musculoskeletal (MSK) symptom framework, which uses the Psoriasis Epidemiology Screening Tool (PEST) and the Psoriatic Arthritis Impact of updated attendees on the IDEOM MSK-Q, a 9-item patient-reported questionnaire designed to measure the intensity and impact of MSK symptoms on the quality of life in patients with psoriasis (PsO) with or without psoriatic arthritis (PsA). Dr. Vibeke Strand summarized the Outcome Measures in Rheumatology (OMERACT) 2023 conference sessions. Dr. April Armstrong discussed the preliminary findings of a multicentered study designed to validate the 7-item Dermatology Treatment Satisfaction Instrument (DermSat-7) among patients with PsO. She also introduced the Psoriasis and Psoriatic Arthritis Treatment Satisfaction Instrument, a tool that seeks to capture the level of patient satisfaction with current therapy for PsO and PsA. This report summarizes the developments discussed at the IDEOM PsO and PsA research workgroups during the GRAPPA 2023 annual meeting.
引用
收藏
页码:16 / 18
页数:3
相关论文
共 4 条
[1]   A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative [J].
Gossec, Laure ;
de Wit, Maarten ;
Kiltz, Uta ;
Braun, Juergen ;
Kalyoncu, Umut ;
Scrivo, Rossana ;
Maccarone, Mara ;
Carton, Laurence ;
Otsa, Kati ;
Sooaeaer, Imre ;
Heiberg, Turid ;
Bertheussen, Heidi ;
Canete, Juan D. ;
Lombarte, Anselm Sanchez ;
Balanescu, Andra ;
Dinte, Alina ;
de Vlam, Kurt ;
Smolen, Josef S. ;
Stamm, Tanja ;
Niedermayer, Dora ;
Bekes, Gabor ;
Veale, Douglas ;
Helliwell, Philip ;
Parkinson, Andrew ;
Luger, Thomas ;
Kvien, Tore K. .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) :1012-1019
[2]   A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience [J].
Kane, D ;
Stafford, L ;
Bresnihan, B ;
FitzGerald, O .
RHEUMATOLOGY, 2003, 42 (12) :1460-1468
[3]   Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics [J].
Mease, Philip J. ;
Gladman, Dafna D. ;
Papp, Kim A. ;
Khraishi, Majed M. ;
Thaci, Diamant ;
Behrens, Frank ;
Northington, Robert ;
Fuiman, Joanne ;
Bananis, Eustratios ;
Boggs, Robert ;
Alvarez, Daniel .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (05) :729-735
[4]  
Perez-Chada Lourdes M, 2021, J Rheumatol Suppl, V97, P10, DOI 10.3899/jrheum.201668